Genor Biopharma Holdings Limited is an innovative biotechnology company engaged in the research, development, and commercialization of biopharmaceutical products. Specializing in oncology and autoimmune diseases, the company's primary aim is to develop and provide novel therapies that address high unmet medical needs. Genor Biopharma harnesses advanced technologies in monoclonal antibodies and recombinant protein products, contributing to significant therapeutic advancements. The company conducts comprehensive clinical trials and maintains a strong pipeline of drug candidates in various stages of development. Based in China, Genor Biopharma plays a crucial role in Asia's burgeoning biotech sector, helping to expand access to cutting-edge medical treatments. Leveraging strategic partnerships with global pharmaceutical companies, the company emphasizes rigorous innovation and research excellence. As a participant in both regional and international markets, Genor Biopharma not only drives forward the biomedical field but also supports the broader healthcare ecosystem through its dedication to scientific research and its commitment to improving patient outcomes.